Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. - Wikidata - wikimedia - TriplyDB

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

http://www.wikidata.org/entity/Q34102715

about

Insight into the Molecular Imaging of Alzheimer's Disease Multimodal neuroimaging computing: the workflows, methods, and platforms Multimodal neuroimaging computing: a review of the applications in neuropsychiatric disorders Characteristics of Tau and Its Ligands in PET Imaging Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease PET amyloid-beta imaging in preclinical Alzheimer's disease Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.Tau PET imaging: present and future directions.Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Preclinical AD Workgroup staging: pathological correlates and potential challenges.Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging.Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls Small organic probes as amyloid specific ligands--past and recent molecular scaffolds.Quantitative evaluation of Alzheimer's disease.The prognostic value of amyloid imaging.Amyloid-β probes: Review of structure-activity and brain-kinetics relationships.Developments in Tau PET Imaging.PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases.Amyloid Imaging: Poised for Integration into Medical Practice.Genetics of Frontotemporal Dementia.Tau Positron Emission Tomography Imaging.Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques.Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.Biomathematical screening of amyloid radiotracers with clinical usefulness index.Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.[Clinically validated molecular biomarkers of neurodegenerative dementia].Imaging Protein Misfolding in the Brain Using β-Sheet Ligands

P2860

Q26765945-6C6849FB-3463-47F8-A8A2-9C12BEE116B2 Q26766359-9D601CE3-A7C6-407D-B338-00F90A300D7D Q26766362-E4437688-BAAC-45B1-8A48-9A3C18D7535D Q26769952-7FDE0D5B-E31E-4B16-8CCD-04AA1DA5314F Q26770766-FDCD126B-99FD-4734-9C1B-7DCD90AD8B1F Q27309046-0E9A83B3-505F-4CF4-9697-149C1F69A52D Q30040695-818F2850-2B03-425B-814A-7CFE3D44458E Q30275833-9E9FE95C-87A0-4C16-A35D-B3AE49FA88E9 Q30422060-474985B2-EF16-45DB-BF56-86872AB8B861 Q34637899-B7E11032-69FB-47D7-B270-B81C44A12D8F Q34680852-E32C7E2B-A56F-4C52-BE35-3F97DEBE13A7 Q35600979-4925408C-3C5E-42E0-8C01-93ABE0C66B2F Q35633470-8339C8EF-97C4-4E52-AC1A-89682B5A2275 Q35776066-22593F32-D721-4E26-983F-11533A738CE4 Q35810005-EAD8D3DD-97CB-4A04-981E-7895446BA2D8 Q35840623-CE349E9F-BDB3-4893-963E-C408DD0CE0FB Q35861376-A51E0EA5-9869-4808-98BB-2117A91627D5 Q36121377-197F3C29-A6FC-4F4C-976D-92894351F115 Q36526176-EA513C24-0855-446A-9E25-538D34C20BCC Q36606287-B731EA48-9B16-41B6-9125-3205D1EA13C7 Q37141423-8551B785-6ECE-4C01-8D08-B336E61D94A3 Q37259426-500CD347-FF83-4A56-8AED-B6CFDC05E554 Q37450061-C604C688-1E7E-4392-9D01-A8A60B3D6901 Q37596431-7DBBCB71-A43E-4382-BED5-0E38204467CC Q38001577-B9B39ADD-328F-46E0-93B5-F86808596AC0 Q38114434-6116AD87-3E38-46DA-87C3-1547CC7D9E8C Q38271405-4542F636-0098-4060-9BD1-D113F0E53BBA Q38510360-BD4AA6DA-96DC-4D3F-AE96-44A9D911FB62 Q38939875-CACD71E8-A0E3-4369-B336-57B31D8AAB7F Q39017699-C4477D8E-857E-44F7-A568-7334A8C88593 Q39035462-A01FF7F7-9E63-4A83-8E72-F7F0BB2A34B3 Q39035486-1A982EEE-541D-4417-BD5C-4B8A1368331F Q39512830-F148D6FD-DCEF-4FE7-9765-C1CA3A0DB20D Q43467553-108C9977-D11F-4483-9A66-9CDB431E6781 Q47140361-65AADFE9-2716-40C8-94F5-DEB44C7E8C24 Q47241835-5ABAB424-17AB-47E7-947F-5B2A74EDB34A Q50764182-4E5D1F11-FA4E-49DE-85CE-EF6B78630FA9 Q53357937-E1205338-8B3F-47CF-B428-BA5E7137BDE4 Q57168250-3BA3D2D0-9B8A-4242-A67D-F372E0180EE2

P2860

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

http://www.wikidata.org/entity/Q34102715

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@ast

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@en

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@nl

type

label

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@ast

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@en

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@nl

prefLabel

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@ast

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@en

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@nl

P1433

Q34102715-6332FEA1-7580-44DA-A72B-0FA23B66E0DB

P1476

Q34102715-66E6CA94-D3E8-48FD-A8F8-D1875ABD6B6C

P2093

Q34102715-0711B38A-4482-48C1-8BF4-E127E830280F

Q34102715-50CD84FF-9F66-4AEF-B98D-75B5715275BC

Q34102715-8C9C1560-5FF9-43F6-800E-5762515B024D

Q34102715-A4A187C3-F762-4D53-8FD3-C67138C16AEE

Q34102715-A8FC5823-FBD5-4B1F-8AF2-5C74CD67F684

Q34102715-DFBA1224-1CF2-4B70-BD40-0430A0C86BD1

Q34102715-F33E027A-2BA4-4D86-8093-5B8851390990

Q34102715-F54E8E10-E864-4562-8D67-5678E38E992B

P2860

Q34102715-0B16457B-92EA-4D35-A010-93F3F25F1AFE

Q34102715-0E0913B5-0AB8-47B2-A75C-C3DBD12A5060

Q34102715-1B479A97-D491-46BF-9B7D-C31735EF4CB7

Q34102715-1BDDE92B-D8F4-435A-AE39-54CE8C88DCF8

Q34102715-1D93E8EE-9CC4-4987-B4CA-8E9E1CDFD6D1

Q34102715-20605B26-8D1A-4B1D-8CB9-75EC33925042

Q34102715-2CDF8787-15EB-4596-BC09-46C4404AEAFF

Q34102715-315AD861-73A3-4223-BECF-19DCA0F2A3CA

Q34102715-369C5CDB-C15C-413D-A24F-B68F27DAE122

Q34102715-44030FB3-4343-4F17-B1AE-D78C066231CB

P304

Q34102715-7053AF66-DB99-43BB-A907-D19901CCAD8D

P31

Q34102715-7E39F1C8-AC71-487B-B1BD-F5D57632D8E9

P356

Q34102715-2C3B7512-DE4D-43E4-84BB-90BD9D200C2E

P407

Q34102715-169F55C7-A161-4685-91D0-94689B747AA3

P433

Q34102715-F9449867-F591-49B6-A699-B5DE8244D03B

P478

Q34102715-FCF87980-DD6E-409A-B0BD-E10827EC4A1A

P50

Q34102715-40F52F54-6D2C-40CE-9702-ED48757A67B4

P577

Q34102715-454DAC58-F9EA-4F97-8983-735CBCF1F507

P5875

Q34102715-76258AA8-7576-4AF0-9D98-6138F14A424B

P698

Q34102715-F4F01B48-E101-438E-8A1C-B8D736E2A9CF

P921

Q34102715-09B8784E-F08F-4C44-A3CC-12D2007AF89F

Q34102715-5317304C-8168-4F55-A3D6-11B8E8C12E12

P932

Q34102715-0D31AB79-CD8B-4A89-BF2A-2C4284DD3D3C

P356

J.1471-4159.2009.05996.X

P1433

Journal of Neurochemistry

P1476

Interaction of the amyloid ima ...... zheimer's disease pathologies.

@en

P2093

Andrew Lockhart

http://www.w3.org/2001/XMLSchema#string

Duncan J Judd

http://www.w3.org/2001/XMLSchema#string

Jennifer L Morgenstern

http://www.w3.org/2001/XMLSchema#string

Liang Ye

http://www.w3.org/2001/XMLSchema#string

Lucia Sue

http://www.w3.org/2001/XMLSchema#string

Nicholas J Shipley

http://www.w3.org/2001/XMLSchema#string

Paul W Thompson

http://www.w3.org/2001/XMLSchema#string

Vincenzo Libri

http://www.w3.org/2001/XMLSchema#string

P2860

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The blood-brain barrier in health and chronic neurodegenerative disorders

In vivo labeling of amyloid with BF-108.

Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

Imaging Alzheimer's disease pathology: one target, many ligands.

P304

623-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2009.05996.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227773621

http://www.w3.org/2001/XMLSchema#string

P698

19226369

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

amyloid imaging

P932

2933070

http://www.w3.org/2001/XMLSchema#string